Ryan Maynard - Insider Trading & Ownership

Entity
Individual
Location
Rigel Pharmaceuticals, Inc., 1180 Veterans Blvd., South San Francisco, CA
Summary
The estimated net worth of Ryan Maynard is at least $420K dollars as of June 13, 2024. Ryan Maynard is the Director of IOVANCE BIOTHERAPEUTICS, INC. and owns shares of IOVANCE BIOTHERAPEUTICS, INC. (IOVA) stock worth about $413K. Ryan Maynard is the CHIEF FINANCIAL OFFICER of Cara Therapeutics, Inc. and owns shares of Cara Therapeutics, Inc. (CARA) stock worth about $7.43K.
All Insider Reports
All Insider Reports

Ownership of Ryan Maynard

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
IOVA IOVANCE BIOTHERAPEUTICS, INC. Director $413K Jun 11, 2024
CARA Cara Therapeutics, Inc. Chief Financial Officer $7.43K Feb 8, 2024

Insider Transactions Reported by Ryan Maynard:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.